...
首页> 外文期刊>The American journal of orthopedics >Tramadol/acetaminophen tablets in the treatment of postsurgical orthopedic pain.
【24h】

Tramadol/acetaminophen tablets in the treatment of postsurgical orthopedic pain.

机译:曲马多/对乙酰氨基酚片治疗骨科术后疼痛。

获取原文
获取原文并翻译 | 示例

摘要

Tramadol/acetaminophen (APAP) combination tablets were shown effective and safe for postsurgical orthopedic pain in a 6-day, multicenter, randomized, double-blind, active- and placebo-controlled study. Of 305 intent-to-treat (ITT) postsurgical patients, 153 patients undergoing arthroscopy who had at least moderate pain were randomized to receive either tramadol 37.5 mg/APAP 325 mg (mean, 4.3 tablets), or codeine 30 mg/APAP 300 mg (mean, 4.6 tablets), or placebo. Tramadol/APAP was superior to placebo for the following outcome variables: total pain relief (TOTPAR, P = .013), sum of pain intensity differences (SPID, P = .049), sum of total pain relief and sum of pain intensity differences (SPRID, P = .018), and average daily pain relief (P = .031). Similar incidence of adverse events for tramadol/APAP and codeine/APAP was found, except for constipation (0% vs 10.9%) and vomiting (8.2% vs 16.4%).
机译:一项为期6天的多中心,随机,双盲,主动和安慰剂对照研究显示,曲马多/对乙酰氨基酚(APAP)组合片剂对骨科术后疼痛有效且安全。在305名意向性治疗(ITT)术后患者中,至少有中度疼痛的153例接受关节镜检查的患者被随机分配接受曲马多37.5 mg / APAP 325 mg(平均4.3片)或可待因30 mg / APAP 300 mg (平均4.6片)或安慰剂。在以下结果变量方面,曲马多/ APAP优于安慰剂:总疼痛缓解(TOTPAR,P = .013),疼痛强度差异总和(SPID,P = .049),总疼痛缓解总和和疼痛强度差异总和(SPRID,P = .018)和平均每日疼痛缓解(P = .031)。除便秘(0%比10.9%)和呕吐(8.2%比16.4%)外,曲马多/ APAP和可待因/ APAP的不良事件发生率相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号